Summary
The aim of this study was to evaluate the usefulness of salmon calcitonin (sCT) in preventing corticosteroid-induced osteoporosis. Three groups of patients with sarcoidosis requiring long-term steroid therapy were followed for 2 years with yearly evaluations of vertebral cancellous mineral content (VCMC) by quantitative computed tomography. The first group (n=18) was treated with intramuscular (i.m.) sCT for the 2-year study period; the second (n=11) with i.m. sCT for the first 4 months and then with sCT nasal spray for 20 months; the third (n=35) received no sCT. We observed a large mineral loss in the third group but a very slight drop of VCMC in the two groups receiving sCT. SCT nasal spray was better tolerated and as effective as i.m. injections. The action of sCT appeared extremely useful, especially in the first year of steroid therapy when corticosteroid-induced mineral loss was maximal. We conclude that sCT nasal spray is a good tool for preventing corticosteroid-induced osteoporosis.
Similar content being viewed by others
References
Bressot C, Meunier PG, Chapuy MC, Lejeune E, Eduoard C, Darby AJ (1979) Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab Bone Dis Rel Res 1:303–319
Dempster DW, Arlot MA, Meunier PJ (1983) Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tissue Int 35:410–417
Frost HM, Villanueva AR (1961) The effect of cortisone on lamellar osteoblastic activity. Henry Ford Hosp Med J 9:97–99
Lukert BP, Raisz LG (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112:352–364
Hahn TJ (1978) Corticosteroid-induced osteopenia. Arch Intern Med 138:882–885
Reid IR (1989) Steroid osteoporosis. Calcif Tissue Int 45:63–67
Suzuki Y, Ichikawa Y, Saito E, Homma M (1983) Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 32:151–156
Reid IR, Ibbertson HK (1987) Evidence for decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics. Hormone Res 27:200–204
Delorne AC, Danan JL, Mathieu H (1983) Biochemical evidence for the presence of two vitamin D-dependent calcium-binding proteins in mouse kidney. J Biol Chem 258:1878–1884
Fucik RF, Kukreja SC, Hargis GK, Bowser EN, Henderson WJ, Williams GA (1975) Effect of glucocorticoids on function of the parathyroid glands in man. J Clin Endocrinol Metab 40:152–155
Riggs BL (1988) Practical management of the patient with osteoporosis. In: Riggs BL, Melton LJ (eds) Osteoporosis: etiology, diagnosis and management. Raven Press, New York, 481–490
Chen TL, Cone CM, Morey-Holton E, Feldman D (1982) Glucocorticoid regulation 1-25(OH)2 vitamin D3 receptors in cultured mouse bone cells. J Biol Chem 257:13564–13569
Chen TL, Cone CM, Morey-Holton E, Feldman D (1983) 1 α 25 dihydroxyvitamin D3 receptors in cultured rat osteoblast-like cells. Glucocorticoid treatment increased receptor content. J Biol Chem 258:4350–4355
Nielsen HK, Eriksen EF, Storm T, Mosekilde L (1988) The effects of short-term, high-dose treatment with prednisone on the nuclear uptake of 1,25-dihydroxyvitamin D3 in monocytes from normal human subjects. Metabolism 37:109–114
Azria M (1989) Endogenous calcitonin. In: Azria M (ed) The calcitonins: physiology and pharmacology. Karger, Basel, p 48
Chesnut CH, Baylink DJ, Gruber HE, Ivey JL, Matthews M, Nelp WB, Sisom K, Taggart HM, Reynolds JC, Roos BA (1984) Synthetic salmon calcitonin in postmenopausal osteoporosis: current concepts. In: Avioli LV, Dambacher MA (eds) Calcitonin: Das therapeutische Potential bei osteoporose. Scharrauer, Stuttgart, New York
Locascio VL, Adami S, Avioli LV, Comicacini L, Galvanini G, Gennari C, Imbimbo B, Scuro LA (1982) Suppressive effect of chronic corticoid treatment on circulating calcitonin in man. Calcif Tissue Int 34:309–311
Rizzato G, Tosi G, Schiraldi G, Montemurro L, Zanni D, Sisti S (1988) Bone protection with salmon calcitonin (sCT) in the long-term steroid therapy of chronic sarcoidosis. Sarcoidosts 5:99–103
Rizzato G, Schiraldi G, Tosi G, Locicero S, Montemurro L, Zanni D, Sisti S (1989) Administration of salmon calcitonin nasal spray for long-term treatment of corticosteroid-induced osteoporosis. A preliminary report. Curr Ther Res 45:761–766
Rizzato G, Tosi G, Mella C, Montemurro L, Zanni D, Sisti S (1988) Prednisone-induced bone loss in sarcoidosis: a risk especially frequent in postmenopausal women. Sarcoidosis 5:93–98
Cann CE, Genant HK (1983) Single versus dual energy CT for vertebral mineral quantification. J Comput Assit Tomogr 7:551–560
Montemurro L, Fraioli P, Riboldi A, Delpiano S, Zanni D, Rizzato G (in press) Bone loss in prednisone-treated sarcoidosis: a follow-up over two years. Ann Ital Med Int
Gluck OS, Murphy WA, Hahn TJ, Hahn B (1981) Bone loss in adults receiving alternate day glucocorticoid therapy. Arthritis Rheum 24:892–898
Baylink DJ (1983) Glucocorticoid-induced osteoporosis. N Engl J Med 309:306–308
Ruegsegger P, Medici TC, Anliker M (1983) Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 25:615–620
Gennari C, Civitelli R (1986) Glucocorticoid-induced osteoporosis. Clin Rheum Dis 12:637–654
Rickers H, Deding A, Christiasen C, Rodbro P, Naestoft J (1982) Corticosteroid-induced osteopenia and vitamin D metabolism. Effect of vitamin D, calcium phosphate and sodium fluoride administration. Clin Endocrinol 16:409–415
Collier GH, Cann CE, Pye KH, Riccardi PR, Genant HK (1982) Multivariate analysis of spinal and peripheral mineral loss in patients with rheumatoid arthritis. Arthritis Rheum 25 (suppl):537–545
Locascio V, Bonucci E, Imbimbo B, Ballanti P, Adami S, Milani S, Tartarotti D, Della Rocca C (1990) Bone loss in response to long-term glucocorticoid therapy. Bone Miner 8:39–51
Montemurro L, Fraioli P, Rizzato G (1991) Bone loss in untreated long-standing sarcoidosis. Sarcoidosis 8:29–34
Spector S, Greenwald M, Silverman SA (1989) Successful treatment of osteoporosis due to steroid-dependent COPD and asthma. Am Rev Resp Dis 139:A16
Riggs BL, Seeman E, Hodgson SF, Taves DR, O'Fallon WM (1982) Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. N Engl J Med 306:446–450
Ringe JD, Welzel D (1987) Salmon calcitonin in the therapy of corticoid-induced osteoporosis. Eur J Clin Pharmacol 33:35–39
Mack TM, Pike MC, Henderson DE (1976) Estrogens and endometrial cancer in a retirement community. N Engl J Med 294:1262–1267
Seeman E, Kumar R, Hunder GC, Scott M, Health H, Riggs BL (1980) Production, degradation and circulating levels of 1–25 dihydroxy vitamin D in health and in chronic glucocorticoid excess. J Clin Invest 66:664–669
Ringe JD, Steinhagen-Thiessen E (1985) Treatment of corticosteroid-induced osteoporosis with salmon calcitonin. In: Masson (ed) 2nd Int Conf on Osteoporosis, pp 371–375
Luengo M, Picado C, Del Rio L, Guanabens N, Montserrat JM, Setoain J (1990) Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma. Am Rev Resp Dis 142:104–107
Reid IR, Katz JM, Ibbertson HK, Gray DH (1986) The effects of hydrocortisone, parathyroid hormone, and the biphosphonate. APD, on bone resorption in neonatal mouse calvaria. Calcif Tissue Int 38:38–43
Avioli LV (1987) Calcitonin in post-menopausal and senile osteoporotic syndromes. In: Cohn DV, Martin TJ, Meunier PJ (eds) Calcium regulation and bone metabolism: basic and clinical aspects. Excerpta Medica. Amsterdam, pp 923–931
Reginster JY, Albert A, Lecart MP, Lambelin P, Denis D, Deroisy R, Fontaine MA, Franchimont P (1987) 1-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet 2:1481–1483
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Montemurro, L., Schiraldi, G., Fraioli, P. et al. Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients. Calcif Tissue Int 49, 71–76 (1991). https://doi.org/10.1007/BF02565124
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02565124